AcelRx Pharmaceuticals Inc(ACRX)
1.02
Change: 0.00 (▲ 0.24%)
As of Wed 10/06/2021 03:01 AM% Of Value
Growth
Value Per Share
:
:
:
-88.70
-47.97
-1.1500 (as of 19/07/2019)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
| Open | 2.55 | Dividend | 45 |
| Close Price | 1.02 | DivYield | 0 % |
| High | 2.72 | Growth | 0.0 |
| Low | 2.47 | Growth% | -47.97 |
| P/e | -6.281 | Volume | 850,629.0 |
| P/b | -0.62 | Market Capital | 121.3 M |
| Highest High | 5.5 | Lowest Low | 1.85 |
| 50 Days Moving Average | 2.65 (as of 18/07/2019) | 50 Days Moving Average Percentage | -58.421 (as of 18/07/2019 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 7.9 M | 2.1 M | 2.2 M | 5.4 M | 2.8 M |
| Cap Spending | -2.4 M | -819,000.0 | -3.4 M | -1.8 M | -1.8 M |
| Operating Expenses | 36.0 M | 33.9 M | 49.6 M | 40.3 M | 35.0 M |
| Operating Cash Flow | -38.6 M | -35.7 M | -54.2 M | -40.9 M | -35.9 M |
| Free Cash Flow | -32.1 M | -29.8 M | -54.6 M | -40.3 M | -31.8 M |
| Free Cash Flow Per Share | -0.686 | -0.512 | -0.69 | -0.473 | -0.266 |
| Total liabilities | 19.0 M | 11.9 M | 29.7 M | 25.5 M | 18.6 M |
| Total cash | 53.0 M | 88.1 M | 14.6 M | 27.2 M | 12.6 M |
| ROE% | 1.745 | 1.458 | 2.218 | 0.705 | 0.987 |
| Outstanding Shares | 50.8 M | 78.7 M | 80.4 M | 118.9 M | 146.9 M |
| P/E | -2.075 | -6.281 | -1.269 | -6.422 | -1.808 |
| P/S | 13.369 | 137.671 | 29.505 | 47.878 | 22.517 |
| Revenue USD | 7.9 M | 2.1 M | 2.2 M | 5.4 M | 2.8 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|